Search Results

PHTPP 100 mg  | 99.72%

TargetMol

PHTPP is a selective ERβ antagonist.

More Information Supplier Page

×

PHTPP

PHTPP 25 mg  | 99.72%

TargetMol

PHTPP is a selective ERβ antagonist.

More Information Supplier Page

×

PHTPP

PHTPP 10 mg  | 99.72%

TargetMol

PHTPP is a selective ERβ antagonist.

More Information Supplier Page

×

PHTPP

PHTPP 5 mg  | 99.72%

TargetMol

PHTPP is a selective ERβ antagonist.

More Information Supplier Page

×

PHTPP

PHTPP 2 mg  | 99.72%

TargetMol

PHTPP is a selective ERβ antagonist.

More Information Supplier Page

×

PHTPP

Sitravatinib 200 mg  | 98.90%

TargetMol

Sitravatinib (MGCD516) is an inhibitor targeting multiple RTKs involved in driving sarcoma cell growth, including c-Met, c-Kit, PDGFRα/β, PDGFR, and Axl.

More Information Supplier Page

×

Sitravatinib

Sitravatinib 100 mg  | 98.90%

TargetMol

Sitravatinib (MGCD516) is an inhibitor targeting multiple RTKs involved in driving sarcoma cell growth, including c-Met, c-Kit, PDGFRα/β, PDGFR, and Axl.

More Information Supplier Page

×

Sitravatinib

FX1 2 mg  | 99.68%

TargetMol

FX1 is an effective and selective BCL6 inhibitor (IC50: 35 μM).

More Information Supplier Page

×

FX1

Pentostatin 100 mg  | 99.47%

TargetMol

Pentostatin is an extremely effective and irreversible inhibitor of adenosine deaminase (Ki: 2.5 pM).

More Information Supplier Page

×

Pentostatin

TOFA 200 mg  | 99.71%

TargetMol

TOFA is an allosteric inhibitor of acetyl-CoA carboxylase-α (ACCA).

More Information Supplier Page

×

TOFA